Paul Chan

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Venous Thromboembolism

Computed Tomography

Cardiovascular Disease

Top Venues

Expert opinion on pharmacotherapy

Clinical interventions in aging

Diabetes, metabolic syndrome and obesity : targets and therapy

International journal of general medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoyu Wang, Xiaoli Chen, Yanfang Wang, Sheng Peng, Jingjiang Pi, Jinnan Yue, Qingshu Meng, Jie Liu, Liang Zheng, Paul Chan, Christopher Wai Kei Lam, Zhongmin Liu, Yuzhen Zhang
The Association of Lipoprotein(a) and Neutrophil-to-Lymphocyte Ratio Combination with Atherosclerotic Cardiovascular Disease in Chinese Patients. International journal of general medicine 16 (2023)
YingLu Wang, Chang Liu, Liping Liu, Xiaoli Chen, Lu Wei, Jie Liu, Sheng Peng, Jingjiang Pi, Qi Zhang, Christopher Wai Kei Lam, Paul Chan, Lin Zhang, Huimin Fan, Liang Zheng, Zhongmin Liu, Yuzhen Zhang
Association of Elevated Thyroid Stimulating Hormone with Atherosclerotic Cardiovascular Disease and Its Mortality in Elderly Community-Dwelling Chinese. Clinical interventions in aging 17 (2022)
Sze Wa Chan, Christopher Wai Kei Lam, Paul Chan, Christopher Wai Kei Lam
The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk. Pharmaceutical biology 59 (1) (2022)
Xiaoli Chen, Jianfei Xu, Wenzhen Bao, Hongda Li, Wenrun Wu, Jiwen Liu, Jingjiang Pi, Christopher Wai Kei Lam, Paul Chan, Cheng-Chao Ruan, Qi Zhang, Lin Zhang, Huimin Fan, Edward Morrisey, Zhongmin Liu, Yuzhen Zhang, Li Lin, Jie Liu, Tao Zhuang
Endothelial Foxp1 Regulates Neointimal Hyperplasia Via Matrix Metalloproteinase-9/Cyclin Dependent Kinase Inhibitor 1B Signal Pathway. Journal of the American Heart Association 11 (15) (2022)
Christopher Wai Kei Lam, Elaine Y K Chow, Paul Chan, Christopher Wai Kei Lam
An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease. Expert opinion on drug metabolism & toxicology 17 (12) (2022)
Christopher Wai Kei Lam, Yan-Hong Li, Paul Chan
Evaluating gliclazide for the treatment of type 2 diabetes mellitus. Expert opinion on pharmacotherapy 23 (17) (2022)
Jingqi Zhu, Zhangwei Yang, Xiaoli Chen, Jie Liu, Liang Zheng, Lin Zhang, Jingjiang Pi, Gang Li, Tao Zhuang, Chang Liu, Yinglu Wang, Liping Liu, Lieying Fan, Paul Chan, Christopher Wai Kei Lam, Ying Li, Zhongmin Liu, Yuzhen Zhang
A Stronger Association of Epicardial Fat Volume with Non-Valvular Atrial Fibrillation Than Measures of General Obesity in Chinese Patients Undergoing Computed Tomography Coronary Angiography. Diabetes, metabolic syndrome and obesity : targets and therapy 14 (2021)
Christopher Wai Kei Lam, Nivritti Gajanan Patil, Manson Fok, Paul Chan, Christopher Wai Kei Lam
The role of sulfonylureas in the treatment of type 2 diabetes. Expert opinion on pharmacotherapy (2021)
Christopher Wai Kei Lam, Paul Chan, Christopher Wai Kei Lam
An overview of alogliptin + pioglitazone for the treatment of type 2 diabetes. Expert opinion on pharmacotherapy (2021)